July 2026 GLP-1 Provider Rankings: Our Updated Top 10
Our updated rankings for July 2026, scored against our published methodology — pricing transparency, clinical oversight, FDA status disclosure, and cancellation terms. No provider pays for placement here.
The current top tier
Embody From $149
Injectable semaglutide with documented clinical review and transparent dose-level pricing.
Paid linkSesame Care From $149
FDA-approved brand-name medications (Wegovy, Ozempic, Zepbound) through a transparent marketplace.
Wellorithm From $147
Compounded semaglutide and tirzepatide with the lowest oral pricing we've tracked in this category.
Strong performers, category-specific
Care Bare Rx From $199
Solid across GLP-1, ED, and NAD+ programs with a get-started quiz flow.
Oak Longevity
Compare treatment availability, consultation and membership charges, pharmacy fees and refill policies. Eligibility and medication choice are determined by a clinician.
Pricing, medication access, service area and plan terms must be confirmed with the provider. This is not a drug-specific checkout link.
Explore Oak Longevity program ↗Affiliate link: we may earn a commission. This is a different provider from the retired program discussed in older comparisons.
What moved since our last update
Pricing across the category has continued to compress as competition increases, and Medicare Bridge eligibility (launched July 1, 2026) has shifted the calculus for older patients specifically toward brand-name pathways where a participating Part D plan applies.
How to use this ranking
These are our top-scoring providers against our published criteria — not a claim that one is universally "best" for you specifically. Your priorities (price, brand-name vs. compounded, state availability) should still guide your final choice; use our provider quiz to narrow based on your specific situation.